Are you ready to turn early science into confident business decisions that shape the future of respiratory and immunology? Can you translate complex data into clear choices that accelerate investment and impact for patients? As Director, Global Early Asset & Business Development within our Insights, Analytics & Forecasting team, you will guide decision‑making from pre‑clinical through Phase 3 preparation and in‑licensing, turning signals into strategy and strategy into action.
You will partner closely with Early Commercial, Finance, Market Access, Medical, and Business Development to bring forward decision‑grade forecasts and market perspectives ahead of critical gates. In a global environment that is embracing predictive analytics, automation, and responsible AI, you will raise the bar on speed, clarity, and rigor—helping the enterprise place smarter bets and build a winning R&I portfolio.